INS and metabolic dysfunction-associated steatotic liver disease: Although the pathophysiology of NAFLD and T2DM are intimately linked, evidence from rodent and human models suggests that distinct molecular pathways serve the ability of insulin to promote lipogenesis and suppress gluconeogenesis [3].